The Hallmark of HIV Infection: Comprehending the Complex Signaling Pathways and Viral Proteins Involved in Disease Progression

Authors

  • Vikas Jha National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India Author
  • Virag Gada Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India Author
  • Divya Dhopeshwarkar Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India Author
  • Shruti Narvekar Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India Author
  • Mehul Nair National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India Author
  • Agraj Bhargava Faculty of Molecular Cell Biology, Universität Bonn, Bonn, Germany Author
  • Mafiz Shaikh National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India Author
  • Navdeep Kaur National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, Indi Author
  • Tisha Jain Department of Five Years Integrated Course in Bioanalytical Sciences, GNIRD, G.N. Khalsa College, Matunga-19, Mumbai, Maharashtra, India Author
  • Kavita Nalawade National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India Author

DOI:

https://doi.org/10.47363/JVRR/2023(4)161

Keywords:

Human Immunodeficiency Virus, AIDS, Signalling, gp120, Pathway, Receptors, Apoptosis

Abstract

HIV can be transmitted from a mother to her child through various means such as blood transfusions, sharing intravenous needles, sexual contact, pregnancy, and breastfeeding. The progression of HIV infection, commonly known as AIDS, involves several stages: viral transmission, acute seroconversion, acute retroviral syndrome, recovery and seroconversion, silent chronic infection, and symptomatic HIV infection. The spread of HIV is considered a pandemic, and since its discovery, an estimated 39 million individuals have lost their lives due to HIV infection, while more than 35 million people are currently living with the disease. Improved medical advancements have led to longer survival for people with HIV, which has contributed to the increased prevalence of HIV/AIDS. Recent studies have focused on understanding the factors that contribute to the varying levels of pathogenicity of the infection, with the aim of finding potential treatments for long-lasting effects. These studies have primarily concentrated on comprehending the defining characteristic of HIV infection, namely the establishment and progression of viral infection through the utilization of its nine major proteins and the complex signaling pathways involved.

Author Biographies

  • Vikas Jha, National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

    Vikas Jha, National Facility for Biopharmaceuticals, Guru Nanak Khalsa college, Mumbai-400019, India

  • Virag Gada, Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

    Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

  • Divya Dhopeshwarkar, Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

    Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

  • Shruti Narvekar, Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

    Department of Biotechnology, Guru Nanak Khalsa College of Arts, Science & Commerce, Mumbai-19, Maharashtra, India

  • Mehul Nair, National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

    National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

  • Agraj Bhargava, Faculty of Molecular Cell Biology, Universität Bonn, Bonn, Germany

    Faculty of Molecular Cell Biology, Universität Bonn, Bonn, Germany

  • Mafiz Shaikh, National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

    National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

  • Navdeep Kaur, National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, Indi

    National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, Indi

  • Tisha Jain, Department of Five Years Integrated Course in Bioanalytical Sciences, GNIRD, G.N. Khalsa College, Matunga-19, Mumbai, Maharashtra, India

    Department of Five Years Integrated Course in Bioanalytical Sciences, GNIRD, G.N. Khalsa College, Matunga-19, Mumbai, Maharashtra, India

  • Kavita Nalawade, National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India


    National Facility for Biopharmaceuticals, G.N. Khalsa College, Matunga, Mumbai, Maharashtra, India

Downloads

Published

2023-11-25